bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.540
-0.460 (-11.50%)
At close: Mar 30, 2026, 4:00 PM EDT
3.520
-0.020 (-0.56%)
Pre-market: Mar 31, 2026, 6:38 AM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $15.91 million as of March 31, 2026. Its market cap has increased by 178.17% in one year.
Market Cap
15.91M
Enterprise Value
10.62M
1-Year Change
178.17%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $15.91M, a decrease of -64.67%. That is a compound annual growth rate of -25.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 15.91M | 200.16% |
| Dec 31, 2025 | 5.30M | -62.63% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MDxHealth | 125.33M |
| FONAR | 121.74M |
| Insight Molecular Diagnostics | 114.52M |
| Exagen | 64.46M |
| Precipio | 45.50M |
| Check-Cap | 11.95M |
| Inotiv | 9.29M |
| XWELL | 6.92M |